# First Business Financial Services, Inc.: financial statements, quarterly

FBIZ · Nasdaq · CIK 1521951 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fbiz.md) · [Financials](/companies/fbiz/financials.md) · [Filings](/companies/fbiz/filings.md) · [Insiders](/companies/fbiz/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fbiz/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [22.3](/filings/0001521951-24-000020.md) | [25.2](/filings/0001521951-24-000020.md) | [26.3](/filings/0001521951-24-000033.md) | [27.4](/filings/0000950170-24-086931.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.1](/filings/0000950170-25-027715.md) | [2.7](/filings/0000950170-25-027715.md) | [1.8](/filings/0001193125-26-071523.md) | [1.9](/filings/0001193125-26-071523.md) | [2.4](/filings/0001193125-26-071523.md) | [0.9](/filings/0001193125-26-071523.md) | [2.3](/filings/0001193125-26-177139.md) | [1.9](/filings/0001193125-26-328468.md) | [3.0](/filings/0001193125-26-071523.md) | [2.9](/filings/0001193125-26-071523.md) | [2.2](/filings/0001193125-26-177139.md) | [1.2](/filings/0001193125-26-328468.md) |
| Net income | $m | [9.9](/filings/0000950170-25-027715.md) | [9.8](/filings/0000950170-25-027715.md) | [8.8](/filings/0001193125-26-071523.md) | [10.5](/filings/0001193125-26-071523.md) | [10.5](/filings/0001193125-26-071523.md) | [14.4](/filings/0001193125-26-071523.md) | [11.2](/filings/0001193125-26-328468.md) | [11.4](/filings/0001193125-26-328468.md) | [14.4](/filings/0001193125-26-071523.md) | [13.3](/filings/0001193125-26-071523.md) | [12.2](/filings/0001193125-26-328468.md) | [15.6](/filings/0001193125-26-328468.md) |
| Diluted EPS | $ per share | [1.17](/filings/0000950170-25-027715.md) | [1.15](/filings/0000950170-25-027715.md) | [1.04](/filings/0001193125-26-071523.md) | [1.23](/filings/0001193125-26-071523.md) | [1.24](/filings/0001193125-26-071523.md) | [1.71](/filings/0001193125-26-071523.md) | [1.32](/filings/0001193125-26-177139.md) | [1.35](/filings/0001193125-26-328468.md) | [1.70](/filings/0001193125-26-071523.md) | [1.58](/filings/0001193125-26-071523.md) | [1.44](/filings/0001193125-26-177139.md) | [1.84](/filings/0001193125-26-328468.md) |
| Basic EPS | $ per share | [1.17](/filings/0000950170-25-027715.md) | [1.15](/filings/0000950170-25-027715.md) | [1.04](/filings/0001193125-26-071523.md) | [1.23](/filings/0001193125-26-071523.md) | [1.24](/filings/0001193125-26-071523.md) | [1.71](/filings/0001193125-26-071523.md) | [1.32](/filings/0001193125-26-177139.md) | [1.35](/filings/0001193125-26-328468.md) | [1.70](/filings/0001193125-26-071523.md) | [1.58](/filings/0001193125-26-071523.md) | [1.44](/filings/0001193125-26-177139.md) | [1.84](/filings/0001193125-26-328468.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [133](/filings/0001521951-23-000083.md) | [140](/filings/0000950170-25-027715.md) | [72.0](/filings/0001521951-24-000033.md) | [81.1](/filings/0000950170-24-086931.md) | [132](/filings/0000950170-24-117408.md) | [158](/filings/0001193125-26-071523.md) | [171](/filings/0000950170-25-058735.md) | [123](/filings/0000950170-25-098776.md) | [44.3](/filings/0001193125-25-260778.md) | [39.5](/filings/0001193125-26-328468.md) | [137](/filings/0001193125-26-177139.md) | [163](/filings/0001193125-26-328468.md) |
| Total assets | $m | [3,419](/filings/0001521951-23-000083.md) | [3,508](/filings/0001193125-26-071523.md) | [3,853](/filings/0000950170-25-058735.md) | [3,853](/filings/0000950170-25-098776.md) | [3,716](/filings/0001193125-25-260778.md) | [3,853](/filings/0001193125-26-071523.md) | [3,945](/filings/0001193125-26-177139.md) | [4,003](/filings/0001193125-26-328468.md) | [4,035](/filings/0001193125-25-260778.md) | [4,082](/filings/0001193125-26-328468.md) | [4,321](/filings/0001193125-26-177139.md) | [4,410](/filings/0001193125-26-328468.md) |
| Total liabilities | $m | [3,138](/filings/0001521951-23-000083.md) | [3,218](/filings/0000950170-25-027715.md) | [3,234](/filings/0001521951-24-000033.md) | [3,312](/filings/0000950170-24-086931.md) | [3,404](/filings/0000950170-24-117408.md) | [3,525](/filings/0001193125-26-071523.md) | [3,609](/filings/0000950170-25-058735.md) | [3,658](/filings/0000950170-25-098776.md) | [3,677](/filings/0001193125-25-260778.md) | [3,710](/filings/0001193125-26-328468.md) | [3,941](/filings/0001193125-26-177139.md) | [4,015](/filings/0001193125-26-328468.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [281](/filings/0000950170-24-117408.md) | [290](/filings/0001193125-26-071523.md) | [298](/filings/0001193125-25-260778.md) | [305](/filings/0001193125-25-260778.md) | [312](/filings/0001193125-25-260778.md) | [329](/filings/0001193125-26-328468.md) | [336](/filings/0001193125-26-328468.md) | [345](/filings/0001193125-26-328468.md) | [358](/filings/0001193125-25-260778.md) | [372](/filings/0001193125-26-328468.md) | [380](/filings/0001193125-26-328468.md) | [395](/filings/0001193125-26-328468.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.5 d](/filings/0000950170-24-117408.md) | [13.3 d](/filings/0001193125-26-071523.md) | [8.7](/filings/0000950170-25-058735.md) | [13.1 d](/filings/0000950170-25-098776.md) | [13.8 d](/filings/0001193125-25-260778.md) | [22.0 d](/filings/0001193125-26-071523.md) | [11.3](/filings/0001193125-26-177139.md) | [15.8 d](/filings/0001193125-26-328468.md) | [18.4 d](/filings/0001193125-25-260778.md) | [16.1 d](/filings/0001193125-26-071523.md) | [3.1](/filings/0001193125-26-177139.md) | [43.8 d](/filings/0001193125-26-328468.md) |
| Capital expenditure | $m | [1.3 d](/filings/0000950170-24-117408.md) | [0.3 d](/filings/0001193125-26-071523.md) | [0.4](/filings/0000950170-25-058735.md) | [0.4 d](/filings/0000950170-25-098776.md) | [(0.6) d](/filings/0001193125-25-260778.md) | [0.0 d](/filings/0001193125-26-071523.md) | [0.1](/filings/0001193125-26-177139.md) | [0.3 d](/filings/0001193125-26-328468.md) | [0.1 d](/filings/0001193125-25-260778.md) | [0.0 d](/filings/0001193125-26-071523.md) | [0.1](/filings/0001193125-26-177139.md) | [0.2 d](/filings/0001193125-26-328468.md) |
| Dividends paid | $m | [1.9 d](/filings/0000950170-24-117408.md) | [1.9 d](/filings/0001193125-26-071523.md) | [2.1](/filings/0000950170-25-058735.md) | [2.1 d](/filings/0000950170-25-098776.md) | [2.1 d](/filings/0001193125-25-260778.md) | [2.1 d](/filings/0001193125-26-071523.md) | [2.4](/filings/0001193125-26-177139.md) | [2.4 d](/filings/0001193125-26-328468.md) | [2.4 d](/filings/0001193125-25-260778.md) | [2.4 d](/filings/0001193125-26-071523.md) | [2.9](/filings/0001193125-26-177139.md) | [3.0 d](/filings/0001193125-26-328468.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-117408.md) | [0.0 d](/filings/0001193125-26-071523.md) | [0.6](/filings/0000950170-25-058735.md) | [0.7 d](/filings/0000950170-25-098776.md) | [0.0 d](/filings/0001193125-25-260778.md) | [0.0 d](/filings/0001193125-26-071523.md) | [0.8](/filings/0001193125-26-177139.md) | [0.6 d](/filings/0001193125-26-328468.md) | [0.0 d](/filings/0001193125-25-260778.md) | [0.0 d](/filings/0001193125-26-071523.md) | [0.8](/filings/0001193125-26-177139.md) | [0.9 d](/filings/0001193125-26-328468.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [8,231](/filings/0001521951-23-000083.md) | [8,149](/filings/0001521951-24-000033.md) | [8,062](/filings/0000950170-24-086931.md) | [8,108](/filings/0000950170-24-117408.md) | [8,125](/filings/0000950170-25-058735.md) | [8,113](/filings/0000950170-25-098776.md) | [8,111](/filings/0001193125-25-260778.md) | [8,131](/filings/0001193125-26-177139.md) | [8,141](/filings/0001193125-26-328468.md) | [8,171](/filings/0001193125-25-260778.md) | [8,186](/filings/0001193125-26-177139.md) | [8,208](/filings/0001193125-26-328468.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 8,368,320 at 2026-07-27, from the cover of the [10-Q filed 2026-07-31](/filings/0001193125-26-328468.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.